Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VGM R02b

X
Drug Profile

VGM R02b

Alternative Names: rAAV9-GCDH; VGM-R02; VGM-R02b

Latest Information Update: 31 May 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Vitalgen BioPharma
  • Class Gene therapies
  • Mechanism of Action Gene transference; Oxidoreductase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glutaric acidemia I
  • New Molecular Entity No

Highest Development Phases

  • Phase I Glutaric acidemia I

Most Recent Events

  • 29 Apr 2024 Phase-I clinical trials in Glutaric acidemia I (In children, In infants, In neonates, Treatment-experienced) in China (Intraventricular) (NCT06217861)
  • 27 Apr 2023 Vitalgen plans a clinical trial of VGM R02b in Glutaric acidemia I in China
  • 11 Jul 2022 Pharmacodynamics data from a preclinical trial in Glutaric acidemia I released by Vitalgen (Vitalgen website,July 2022)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top